Arabesque Asset Management LTD Abbott Laboratories Transaction History

Arabesque Asset Management LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.77 Million - $2.08 Million	18,664 Added 101.59%	37,035 $4.07 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $298,146 - $360,363	-2,921 Reduced 13.72%	18,371 $2 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $81,524 - $99,413	-715 Reduced 3.25%	21,292 $2.52 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $96,352 - $117,977	-834 Reduced 3.65%	22,007 $3.1 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $520,653 - $575,994	-4,463 Reduced 16.35%	22,841 $2.7 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $2.89 Million - $3.4 Million	27,304 New	27,304 $3.17 Million
Q1 2020 Apr 17, 2020	SELL	$62.82 - $91.86 $1.71 Million - $2.5 Million	-27,169 Closed	0 $0
Q4 2019 Jan 30, 2020	SELL	$78.51 - $87.4 $5,260 - $5,855	-67 Reduced 0.25%	27,169 $2.36 Million
Q3 2019 Oct 25, 2019	BUY	$81.84 - $88.74 $150,258 - $162,926	1,836 Added 7.23%	27,236 $2.28 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $1.67 Million - $1.89 Million	25,400 New	25,400 $1.84 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Arabesque Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Arabesque Asset Management LTD with notifications on news.